Difficulty: Medium
Average Score: 75%
Practice
The incidence of ischemic stroke in patients with TIAs and other risk factors is reduced with the administration of which medication?
Correct answer
C
Rationale
In the context of neurological system assessment and stroke prevention, the correct answer to the question is option C) Daily low-dose aspirin. This is because aspirin, specifically in low doses, is a well-established medication for reducing the risk of ischemic stroke in patients with TIAs (transient ischemic attacks) and other risk factors. Aspirin works by inhibiting platelet aggregation, thereby reducing the formation of blood clots that can lead to blockages in the blood vessels supplying the brain, causing an ischemic stroke.
Option A) Furosemide (Lasix) is a diuretic often used to manage fluid retention but does not play a role in stroke prevention. Option B) Lovastatin (Mevacor) is a statin medication used to lower cholesterol levels and prevent cardiovascular events but is not specifically indicated for stroke prevention. Option D) Nimodipine (Nimotop) is a calcium channel blocker that is used in certain situations related to subarachnoid hemorrhage but is not the recommended medication for reducing the risk of ischemic stroke in patients with TIAs.
In an educational context, understanding the appropriate medications for stroke prevention is crucial for healthcare professionals involved in assessing and managing patients at risk for cerebrovascular events. By knowing the rationale behind the use of daily low-dose aspirin in this population, healthcare providers can make informed decisions to optimize patient care and reduce the incidence of ischemic strokes. It is essential to reinforce the importance of evidence-based practice and staying updated on current guidelines to deliver high-quality care to patients at risk for stroke.
Option A) Furosemide (Lasix) is a diuretic often used to manage fluid retention but does not play a role in stroke prevention. Option B) Lovastatin (Mevacor) is a statin medication used to lower cholesterol levels and prevent cardiovascular events but is not specifically indicated for stroke prevention. Option D) Nimodipine (Nimotop) is a calcium channel blocker that is used in certain situations related to subarachnoid hemorrhage but is not the recommended medication for reducing the risk of ischemic stroke in patients with TIAs.
In an educational context, understanding the appropriate medications for stroke prevention is crucial for healthcare professionals involved in assessing and managing patients at risk for cerebrovascular events. By knowing the rationale behind the use of daily low-dose aspirin in this population, healthcare providers can make informed decisions to optimize patient care and reduce the incidence of ischemic strokes. It is essential to reinforce the importance of evidence-based practice and staying updated on current guidelines to deliver high-quality care to patients at risk for stroke.